Pursuant to Regulation 30 of Listing Regulations, Wockhardt has enclosed Press Release - ‘US FDA Accepts Wockhardt’s New Drug Application for Breakthrough Antibiotic Zaynich’. A copy of the same will also be uploaded on the Company’s website www.wockhardt.com.
The above information is a part of company’s filings submitted to BSE.